IMPACT OF HEALTH POLICY CHANGES ON TRENDS OF PHARMACEUTICAL MARKET IN TURKEY

Author(s)

Safak Yilmaz E1, Kockaya G2, Yenilmez FB3, Saylan M2, Tatar M3, Hilal Vural E1, Vural IM1, Akbulat A1, Gursoz H1, Artiran G1, Kerman S1
1Turkish Medicines and Medical Devices Agency, Ankara, Turkey, 2Health Economics and Policy Association, Ankra, Turkey, 3Hacettepe University, Ankara, Turkey

OBJECTIVES: Turkish Ministry of Health(MoH) initiated Health Transformation Program(HTP) in 2002. HTP impacted all clinical and economic outcomes of health including pharmaceutical sales by improving access to health services. Total pharmaceutical market reached US $ 8 billion in last 10 years. HTP improved health coverage and access to health services, additional policies are implemented by MoH for controlling this increasing trend on pharmaceutical consumption. The aim of this analysis is to understand the impact of selected 5 major policy changes to total pharmaceutical consumption in between 2002-2012. METHODS:

Conference/Value in Health Info

2014-11, ISPOR Europe 2014, Amsterdam, The Netherlands

Value in Health, Vol. 17, No. 7 (November 2014)

Code

PHP22

Topic

Health Policy & Regulatory

Topic Subcategory

Pricing Policy & Schemes

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×